← All trials
NCT05105412
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2021
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Nov 3, 2021
- Last posted
- Nov 3, 2021
- Enrollment
- 33
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of TaiwanLead sponsor
- China Medical UniversityCollaborator
- Chang Gung UniversityCollaborator
- National Taiwan UniversityCollaborator
- National Cheng Kung UniversityCollaborator
- Taiwan Cooperative Oncology GroupStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.